Apr. 23, 2021 

[S. 578] 

21 USC 301 note. Food Allergy Safety, Treatment, Education, and Research Act of 2021. 

21 USC 321 note. 

Recommenda- tions. Strategies. 

# Public Law 117–11 117th Congress 

To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein- induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes. 

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, 

## SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Food Allergy Safety, Treatment, Education, and Research Act of 2021’’ or the ‘‘FASTER Act of 2021’’. 

## SEC. 2. FOOD ALLERGY SAFETY. 

(a) IN GENERAL.—Section 201(qq)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321(qq)(1)) is amended by striking ‘‘and soybeans’’ and inserting ‘‘soybeans, and sesame’’. 

(b) EFFECTIVE DATE.—The amendment made by subsection (a) shall apply to any food that is introduced or delivered for introduc- tion into interstate commerce on or after January 1, 2023. 

## SEC. 3. REPORT TO CONGRESS. 

(a) REPORT.—Not later than 18 months after the date of enact- ment of this Act, the Secretary of Health and Human Services (referred to in this section as the ‘‘Secretary’’) shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report that includes— 

(2) specific recommendations and strategies to expand, enhance, or improve activities described in paragraph (1), including— 

(1) descriptions of ongoing Federal activities related to— 

(A) the surveillance and collection of data on the preva- lence of food allergies and severity of allergic reactions for specific food or food ingredients, including the identifica- tion of any gaps in such activities; 

(B) the development of effective food allergy diagnostics; 

(C) the prevention of the onset of food allergies; 

(D) the reduction of risks related to living with food allergies; and 

(E) the development of new therapeutics to prevent, treat, cure, and manage food allergies; and 

(A) strategies to improve the accuracy of food allergy prevalence data by expanding and intensifying current 

# An Act 

